Cargando…

Agent specific effects of anticoagulant induced alopecia

Alopecia has been observed with many anticoagulants although the mechanism is unclear. A 20 year old female with recurrent DVTs developed alopecia with multiple anticoagulants, including heparin derivatives and the new oral anticoagulants. This resolved with discontinuation of the agents. The patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Weyand, Angela C., Shavit, Jordan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645796/
https://www.ncbi.nlm.nih.gov/pubmed/29057391
http://dx.doi.org/10.1002/rth2.12001
_version_ 1783271959107207168
author Weyand, Angela C.
Shavit, Jordan A.
author_facet Weyand, Angela C.
Shavit, Jordan A.
author_sort Weyand, Angela C.
collection PubMed
description Alopecia has been observed with many anticoagulants although the mechanism is unclear. A 20 year old female with recurrent DVTs developed alopecia with multiple anticoagulants, including heparin derivatives and the new oral anticoagulants. This resolved with discontinuation of the agents. The patient was ultimately able to be anticoagulated with fondaparinux long term without any alopecia. This case addresses the Key Clinical Question of management and recognition of anticoagulant induced alopecia. This side effect can result from almost any of the available agents and is quickly reversible, underlining the importance of tailoring treatment to the individual and their experiences.
format Online
Article
Text
id pubmed-5645796
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56457962018-07-01 Agent specific effects of anticoagulant induced alopecia Weyand, Angela C. Shavit, Jordan A. Res Pract Thromb Haemost Case Report Alopecia has been observed with many anticoagulants although the mechanism is unclear. A 20 year old female with recurrent DVTs developed alopecia with multiple anticoagulants, including heparin derivatives and the new oral anticoagulants. This resolved with discontinuation of the agents. The patient was ultimately able to be anticoagulated with fondaparinux long term without any alopecia. This case addresses the Key Clinical Question of management and recognition of anticoagulant induced alopecia. This side effect can result from almost any of the available agents and is quickly reversible, underlining the importance of tailoring treatment to the individual and their experiences. John Wiley and Sons Inc. 2017-05-30 /pmc/articles/PMC5645796/ /pubmed/29057391 http://dx.doi.org/10.1002/rth2.12001 Text en © 2017 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Weyand, Angela C.
Shavit, Jordan A.
Agent specific effects of anticoagulant induced alopecia
title Agent specific effects of anticoagulant induced alopecia
title_full Agent specific effects of anticoagulant induced alopecia
title_fullStr Agent specific effects of anticoagulant induced alopecia
title_full_unstemmed Agent specific effects of anticoagulant induced alopecia
title_short Agent specific effects of anticoagulant induced alopecia
title_sort agent specific effects of anticoagulant induced alopecia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645796/
https://www.ncbi.nlm.nih.gov/pubmed/29057391
http://dx.doi.org/10.1002/rth2.12001
work_keys_str_mv AT weyandangelac agentspecificeffectsofanticoagulantinducedalopecia
AT shavitjordana agentspecificeffectsofanticoagulantinducedalopecia